BIVDA Press Releases

Jun 27, 2022
BIVDA welcomes MHRA’s formal response to the consultation on future regulation of medical devices in the UK The response to the consultation on the new UK Regulatory Framework for medical devices was published on 26 June 2022. This is a huge step for regulation in the UK and gives an insight into what can be expected when the regulations are published. Totalling 16 chapters and spanning 155 pages, the response is very comprehensive and detailed. This depth has been anticipated by the ...
Read More
May 26, 2022
BIVDA welcomes the In Vitro Diagnostic Medical Devices Regulation and urges continued work to deploy the new regulatory system.
Read More
Apr 29, 2022
BIVDA, the UK’s in vitro diagnostics trade association, has commented on the passing of the Health and Care Bill into law which took place yesterday.  Our 200+ IVD member companies supply or support key diagnostic technologies and stand-alone products to the NHS. Stability of these supply chains, commissioning processes and specifics regarding purchase tenders are critical factors to the protection of UK diagnostic care and optimised patient outcomes.  We support the integration ...
Read More
Apr 05, 2022
BIVDA is pleased to contribute to the ‘Week of Action’ led by the Stick to Science alliance, from 4-8 April in support of the campaign to finalise the UK’s formal association to the €95.5 billion (£79.8 billion) Horizon Europe programme. This ongoing impasse is threatening to stifle vital scientific, medical and diagnostic research efforts that underpin novel approaches to medical care, scientific and technological innovation.  Research has never been more impor...
Read More
Mar 25, 2022
For Immediate Release -- Helen Tucker (Thermo Fisher Scientific) has been elected as Chair of the BIVDA Board effective March 24th 2022 for a three-year term. Helen will look to build upon the excellent work of her predecessor, Darren Stenlake (Sysmex UK Ltd), in presenting BIVDA’s strategy and vision to all stakeholders going forward.  Doris-Ann Williams, Chief Executive of BIVDA said: “We are delighted to welcome Helen Tucker as our new Chair following BIVDA’s annua...
Read More
Mar 14, 2022
BIVDA Statement - BIVDA responds to the BEIS R&D partner organisation budget  For Immediate Release -  The Government’s commitment to increasing the R&D budget to £39.8 billion – the largest ever – is welcomed by BIVDA. As the UK’s most representative association for in vitro diagnostic (IVD) technology and innovation, we acknowledge that this investment will provide our industry with vital funds to be able to pioneer cutting-edge researc...
Read More
Mar 02, 2022
BIVDA, the UK’s leading association for in vitro diagnostic (IVD) technology and innovation, welcomes the £200 million in funding announced by BEIS and DHSC to support critical health research into diagnostics and treatment through enhanced data access and digital clinical trial services. Following on from the Medicines and Diagnostics Manufacturing Transformation Fund, a new £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) will help to broaden the commercial-sca...
Read More
Mar 01, 2022
BIVDA welcomes today’s announcement by NHS chief executive Amanda Pritchard of a new campaign which encourages the public to get tested early if they fear they may have cancer.
Read More
Feb 09, 2022
BIVDA welcomes the Secretary of State’s acknowledgement of the importance of diagnostics during the pandemic. Diagnostic testing is fundamental to cutting waiting lists, spotting life-threatening illnesses, and ensuring the UK clears the elective care backlog rapidly and efficiently. As has been noted, currently only 75% of people needing a diagnostic test received one within six weeks – a fall from 96% before the pandemic. We are encouraged by the Secretary of State’s goa...
Read More
Feb 09, 2022
First of its kind coalition sees health industry, professional bodies and experts come together to holistically tackle ‘hidden pandemic’ of antibiotic resistant infections  COVID-19 has shone a light on the need to consider infection management as a whole Coined as the ‘hidden pandemic’, concerns are rising that antibiotic resistant infections are already presenting the next global health crisis A whole system approach is required for the way infection is detected, m...
Read More
Page 1 of 11 FirstPrevious [1]